PLIANT THERAPEUTICS, INC. (PLRX)

Import this data to Google Sheets with:

=jivedata("PLRX","financials")

Full statements spill as a table. For one cell: =jivedata("PLRX","Revenue") or =jivedata("PLRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

PLIANT THERAPEUTICS, INC.

PLRX • CIK 0001746473

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$1,580	$0	$0	$0
Operating Income (Loss)	$-184,145	$-228,365	$-156,373	$-97,480
InterestExpenseNonoperating	—	$3,024	$2,559	$951
Gain (Loss) on Extinguishment of Debt	—	—	$-1,828	$-1,828
Net Income (Loss) Attributable to Parent	$-161,336	$-210,304	$-149,344	$-92,289
Weighted Average Number of Shares Outstanding, Basic	58,719,083	60,538,639	61,366,887	61,923,676
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-159,033	$-210,328	$-149,680	$-92,685
Research and Development Expense	$127,797	$169,310	$109,157	$63,834
General and Administrative Expense	$57,928	$59,055	$47,216	$33,646
Operating Expenses	$185,725	$228,365	$156,373	$97,480
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$2,303	$-24	$-336	$-396

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$63,234	$71,188	$45,445	$24,883
Short-term Investments	$431,011	$284,536	$145,499	$133,218
Property, Plant and Equipment, Net	$3,567	$5,525	$2,940	$2,414
Prepaid Expense and Other Assets, Current	$11,257	$6,540	$4,464	$4,135
Operating Lease, Right-of-Use Asset	$1,211	$27,243	$23,966	$22,289
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current	—	—	$1,040	$906
Restricted Cash, Noncurrent	$1,482	$1,482	$1,482	$1,482
Assets, Current	$505,502	$362,264	$196,448	$163,142
Other Assets, Noncurrent	$392	$435	$392	$554
Assets	$512,154	$396,949	$225,228	$189,881
Operating Lease, Liability, Noncurrent	$0	$29,439	$27,658	$26,471
Long-term Debt	$10,054	$30,211	$0	$0
Liabilities	$38,578	$92,868	$44,023	$42,955
Accounts Payable, Current	$4,531	$5,960	$480	$1,531
Accrued Liabilities, Current	$10,219	$12,353	$9,634	$3,653
Operating Lease, Liability, Current	$1,318	$542	$1,447	$2,272
Liabilities, Current	$28,524	$33,218	$16,365	$16,484
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$6	$6	$6	$6
Additional Paid in Capital, Common Stock	$972,973	$1,013,806	$1,040,610	$1,049,124
Retained Earnings (Accumulated Deficit)	$-499,748	$-710,052	$-859,396	$-901,807
Accumulated Other Comprehensive Income (Loss), Net of Tax	$345	$321	$-15	$-397
Stockholders' Equity Attributable to Parent	$473,576	$304,081	$181,205	$146,926
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	59,921,002	60,860,838	61,449,290	61,920,154

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-161,336	$-210,304	$-149,344	$-92,289
Net Cash Provided by (Used in) Operating Activities	$-116,361	$-155,503	$-128,336	$-70,895
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$31,032	$7,954	$-25,743	$-61,937
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$64,716	$72,670	$46,927	$-22,819
Depreciation	$1,841	$2,125	$1,696	$1,314
Payments to Acquire Short-term Investments	$583,069	$211,285	$203,404	$219,864
Share-based Payment Arrangement, Noncash Expense	$44,483	$37,626	$26,234	$19,384
Proceeds from Maturities, Prepayments and Calls of Short-term Investments	$456,978	$355,473	$337,913	$260,669
Gain (Loss) on Disposition of Property Plant Equipment	—	—	$44	$138
Payments to Acquire Property, Plant, and Equipment	$921	$3,848	$374	$0
Operating Lease, Right-of-Use Asset, Amortization Expense	$2,390	$3,451	$3,277	$3,326
Proceeds from Sale of Property, Plant, and Equipment	—	—	$155	$274
Net Cash Provided by (Used in) Investing Activities	$-127,012	$140,340	$134,290	$41,079
Gain (Loss) on Extinguishment of Debt	—	—	$-1,828	$-1,828
Repayments of Debt	—	—	$32,267	$32,267
Proceeds from Issuance of Debt	$0	$19,910	$0	$0
Net Cash Provided by (Used in) Financing Activities	$274,405	$23,117	$-31,697	$-32,121
Interest Paid, Excluding Capitalized Interest, Operating Activities	$1,149	$2,620	$2,539	$1,082
Cash Equivalents, at Carrying Value	—	—	$45,445	$-24,301
Restricted Cash	$1,482	$1,482	$1,482	$1,482
Capital Expenditures Incurred but Not yet Paid	$0	$236	$112	$0
Operating Lease, Payments	$3,846	$4,698	$5,562	$5,562
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$0	$29,779	$0	$0
Increase (Decrease) in Prepaid Expense and Other Assets	$3,735	$-4,717	$-2,541	$-1,352
Increase (Decrease) in Other Noncurrent Assets	$0	$43	$-43	$-131
Increase (Decrease) in Accounts Payable	$2,969	$1,428	$-5,480	$151
Increase (Decrease) in Accrued Liabilities	$2,781	$3,807	$-12,167	$-5,597
IncreaseDecreaseInOperatingLeaseLiability	$-2,747	$-820	$-876	$-1,273

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("PLRX","financials")

Full statements spill as a table. For one cell: =jivedata("PLRX","Revenue") or =jivedata("PLRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.